LORAZEPAM News

← Back to News Overview


LORAZEPAM currently has 0 news articles, with 18 predicted indications.

This page combines the AI-predicted indications for LORAZEPAM with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Evidence level: L5
  • Predicted indications (18):
    • early myoclonic encephalopathy (99.0%)
    • status epilepticus (99.0%)
    • anxiety disorder (99.0%)
    • absence epilepsy (99.0%)
    • anxiety (99.0%)
    • cutis verticis gyrata (99.0%)
    • Lennox-Gastaut syndrome (99.0%)
    • visual epilepsy (99.0%)
    • trigeminal nerve neoplasm (99.9%)
    • insomnia (disease) (99.8%)
    • reading seizures (99.6%)
    • thinking seizures (99.6%)
    • eating seizures (99.6%)
    • startle epilepsy (99.6%)
    • micturation-induced seizures (99.6%)
    • orgasm-induced seizures (99.6%)
    • audiogenic seizures (99.6%)
    • acute encephalopathy with biphasic seizures and late reduced diffusion (99.5%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.